<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38461701</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>On the merits and potential of advanced neuroimaging techniques in COVID-19: A scoping review.</ArticleTitle><Pagination><StartPage>103589</StartPage><MedlinePgn>103589</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103589</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2024.103589</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(24)00028-7</ELocationID><Abstract><AbstractText>Many Coronavirus Disease 2019 (COVID-19) patients are suffering from long-term neuropsychological sequelae. These patients may benefit from a better understanding of the underlying neuropathophysiological mechanisms and identification of potential biomarkers and treatment targets. Structural clinical neuroimaging techniques have limited ability to visualize subtle cerebral abnormalities and to investigate brain function. This scoping review assesses the merits and potential of advanced neuroimaging techniques in COVID-19 using literature including advanced neuroimaging or postmortem analyses in adult COVID-19 patients published from the start of the pandemic until December 2023. Findings were summarized according to distinct categories of reported cerebral abnormalities revealed by different imaging techniques. Although no unified COVID-19-specific pattern could be subtracted, a broad range of cerebral abnormalities were revealed by advanced neuroimaging (likely attributable to hypoxic, vascular, and inflammatory pathology), even in absence of structural clinical imaging findings. These abnormalities are validated by postmortem examinations. This scoping review emphasizes the added value of advanced neuroimaging compared to structural clinical imaging and highlights implications for brain functioning and long-term consequences in COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Knaap</LastName><ForeName>Noa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Radiology &amp; Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Research Institute of Mental Health &amp; Neuroscience, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ari&#xeb;s</LastName><ForeName>Marcel J H</ForeName><Initials>MJH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Research Institute of Mental Health &amp; Neuroscience, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Horst</LastName><ForeName>Iwan C C</ForeName><Initials>ICC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Jacobus F A</ForeName><Initials>JFA</Initials><AffiliationInfo><Affiliation>Department of Radiology &amp; Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Research Institute of Mental Health &amp; Neuroscience, Maastricht University, Maastricht, the Netherlands; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands. Electronic address: Jacobus.jansen@mumc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="Y">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advanced neuroimaging</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Positron emission tomography</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>10</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38461701</ArticleId><ArticleId IdType="pmc">PMC10938171</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2024.103589</ArticleId><ArticleId IdType="pii">S2213-1582(24)00028-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abel S., Vavasour I., Lee L.E., Johnson P., Ackermans N., Chan J., et al. Myelin damage in Normal appearing white matter contributes to impaired cognitive processing speed in multiple sclerosis. J. Neuroimaging. 2020;30(2):205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">31762132</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Jain R., Dogra S., Krieger P., Lewis A., Nguyen V., et al. Cerebral microbleeds and leukoencephalopathy in critically ill patients with COVID-19. Stroke. 2020;51(9):2649&#x2013;2655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434006</ArticleId><ArticleId IdType="pubmed">32755456</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Farfel J.M., Arfanakis K., Al-Harthi L., Shull T., Teppen T.L., et al. Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases. Acta Neuropathol. Commun. 2022;10(1):186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9758667</ArticleId><ArticleId IdType="pubmed">36528671</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107; M., Iscra K., Furlanis G., Michelutti M., Miladinovi&#x107; A., Buoite Stella A., et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 2023;13(1):5808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz E.A., Amarilla A.A., Modhiran N., Parker S., Li X.X., Wijesundara D.K., et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatry. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardellier F.D., Baloglu S., Sokolska M., Noblet V., Lersy F., Collange O., et al. Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: a retrospective multicenter observational study. J. Neuroradiol. 2023;50(5):470&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9842391</ArticleId><ArticleId IdType="pubmed">36657613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., Kushner S.A., Harschnitz O., van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45(5):358&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG, DeTure M, Walker JE, Arce R, Glass MJ, Sue LI, et al. White Matter &#x3b2;-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19. medRxiv. 2021:2021.12.16.21266656.</Citation></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40(5):905&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bispo D.D.C., Brand&#xe3;o P.R.P., Pereira D.A., Maluf F.B., Dias B.A., Paranhos H.R., et al. Brain microstructural changes and fatigue after COVID-19. Front. Neurol. 2022;13:1029302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9685991</ArticleId><ArticleId IdType="pubmed">36438956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bispo D.D.C., Brand&#xe3;o P.R.P., Pereira D.A., Maluf F.B., Dias B.A., Paranhos H.R., et al. Altered structural connectivity in olfactory disfunction after mild COVID-19 using probabilistic tractography. Sci. Rep. 2023;13(1):12886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10412532</ArticleId><ArticleId IdType="pubmed">37558765</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., Lepra M., Kish S.J., Rusjan P.M., Nasser Z., Verhoeff N., et al. Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms. JAMA Psychiat. 2023;80(8):787&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Callen A.L., Tanabe J., Thaker A.A., Pollard R., Sauer B., Jones W., et al. Evaluation of cerebrovascular reactivity and Vessel Wall imaging in patients with prior COVID-19: a prospective case-control MRI study. AJR Am. J. Roentgenol. 2023;220(2):257&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">36000667</ArticleId></ArticleIdList></Reference><Reference><Citation>Campabadal A., Oltra J., Junqu&#xe9; C., Guillen N., Bot&#xed; M., Sala-Llonch R., et al. Structural brain changes in post-acute COVID-19 patients with persistent olfactory dysfunction. Ann. Clin. Transl. Neurol. 2023;10(2):195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878006</ArticleId><ArticleId IdType="pubmed">36525472</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M, Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, et al. Blood-brain barrier disruption in Long COVID-associated cognitive impairment. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattarinussi G., Miola A., Trevisan N., Valeggia S., Tramarin E., Mucignat C., et al. Altered brain regional homogeneity is associated with depressive symptoms in COVID-19. J. Affect. Disord. 2022;313:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9233546</ArticleId><ArticleId IdType="pubmed">35764231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chammas A., Bund C., Lersy F., Brisset J.C., Ardellier F.D., Kremer S., et al. Collicular hyperactivation in patients with COVID-19: a new finding on brain MRI and PET/CT. AJNR Am. J. Neuroradiol. 2021;42(8):1410&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367604</ArticleId><ArticleId IdType="pubmed">34016586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Ryan M.C., Liang H., Zhang X., Cunningham E., Wang J., et al. Changes in brain activation patterns during working memory tasks in people with post-COVID condition and persistent neuropsychiatric symptoms. Neurology. 2023;100(23):e2409&#x2013;e2423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10256123</ArticleId><ArticleId IdType="pubmed">37185175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.J., Gauthier C.J. The role of cerebrovascular-reactivity mapping in functional MRI: calibrated fMRI and resting-state fMRI. Front. Physiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027080</ArticleId><ArticleId IdType="pubmed">33841190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chougar L., Shor N., Weiss N., Galanaud D., Leclercq D., Mathon B., et al. Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations. Radiology. 2020;297(3):E313&#x2013;E323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370354</ArticleId><ArticleId IdType="pubmed">32677875</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill N.W., Roudaia E., Jean Chen J., Gilboa A., Sekuler A., Ji X., et al. Persistent post-COVID headache is associated with suppression of scale-free functional brain dynamics in non-hospitalized individuals. Brain Behav. 2023;13(11):e3212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10636408</ArticleId><ArticleId IdType="pubmed">37872889</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo D., Falasca L., Marchioni L., Tammaro A., Adebanjo G.A.R., Ippolito G., et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells. 2021;10(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469459</ArticleId><ArticleId IdType="pubmed">34571912</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J., Frosch M.P., Mukerji S.S., Rapalino O., Maher M.D., Schaefer P.W., et al. Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J. Neurol. Sci. 2021;421</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T., Lolli V., Sadeghi N., Rovai A., Trotta N., Taccone F.S., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95(14):e2016&#x2013;e2027.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Ramirez A., Hosseini A.A., Vavougyios G., Lehmann C., Bruchfeld J., et al. European working group on SARS-CoV-2: current understanding, unknowns, and recommendations on the neurological complications of COVID-19. brain. Connect. 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">36719785</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Debs P., Khalili N., Solnes L., Al-Zaghal A., Sair H.I., Yedavalli V., et al. Post-COVID-19 brain [(18)F] FDG-PET findings: a retrospective single-center study in the United States. AJNR Am. J. Neuroradiol. 2023;44(5):517&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10171380</ArticleId><ArticleId IdType="pubmed">37105680</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., et al. Post-COVID-19 syndrome in outpatients: a cohort study. J. Gen. Intern. Med. 2022;37(8):1943&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., Yus M., G&#xf3;mez-Ruiz N., Polidura C., Gil-Mart&#xed;nez L., Delgado-Alonso C., et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., Yus-Fuertes M., Sanchez-Sanchez R., Gonzalez-Rosa J.J., Gonzalez-Escamilla G., Gil-Mart&#xed;nez L., et al. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. EBioMedicine. 2023;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10366393</ArticleId><ArticleId IdType="pubmed">37453364</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Drenthen G.S., Backes W.H., Aldenkamp A.P., Vermeulen R.J., Klinkenberg S., Jansen J.F.A. On the merits of non-invasive myelin imaging in epilepsy, a literature review. J. Neurosci. Methods. 2020;338</Citation><ArticleIdList><ArticleId IdType="pubmed">32173402</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A., Bormann T., Blazhenets G., Schroeter N., Walter L.I., Thurow J., et al. Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J. Nucl. Med. 2022;63(7):1058&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbert A.R., Cankurtaran S., Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: a rapid systematic review. Brain Behav. Immun. 2020;89:543&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366124</ArticleId><ArticleId IdType="pubmed">32682993</ArticleId></ArticleIdList></Reference><Reference><Citation>Elschot E.P., Backes W.H., Postma A.A., van Oostenbrugge R.J., Staals J., Rouhl R.P.W., et al. A comprehensive view on MRI techniques for imaging blood-brain barrier integrity. Invest. Radiol. 2021;56(1):10&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">32932377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst T., Ryan M.C., Liang H.J., Wang J.P., Cunningham E., Saleh M.G., et al. Neuronal and glial metabolite abnormalities in participants with persistent neuropsychiatric symptoms after COVID-19: a brain proton magnetic resonance spectroscopy study. J Infect Dis. 2023;228(11):1559&#x2013;1570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10681871</ArticleId><ArticleId IdType="pubmed">37540098</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbacher K.L., Larsen R.A., Moyer A.M., Majumdar R., Reichard R.R. Neuropathological findings in COVID-19: an autopsy cohort. J. Neuropathol. Exp. Neurol. 2022;82(1):21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">36355625</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito F., Cirillo M., De Micco R., Caiazzo G., Siciliano M., Russo A.G., et al. Olfactory loss and brain connectivity after COVID-19. Hum. Brain Mapp. 2022;43(5):1548&#x2013;1560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886650</ArticleId><ArticleId IdType="pubmed">35083823</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri V.P., Riefolo M., Lazzarotto T., Gabrielli L., Cenacchi G., Gallo C., et al. COVID-19 and the brain: the neuropathological italian experience on 33 adult autopsies. Biomolecules. 2022;12(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9138268</ArticleId><ArticleId IdType="pubmed">35625558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D., Snider S.B., Barra M.E., Sanders W.R., Rapalino O., Schaefer P., et al. Disorders of consciousness associated with COVID-19: a prospective multimodal study of recovery and brain connectivity. Neurology. 2022;98(3):e315&#x2013;e325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792809</ArticleId><ArticleId IdType="pubmed">34862317</ArticleId></ArticleIdList></Reference><Reference><Citation>Florensa D., Mateo J., Spaimoc R., Miret C., Godoy S., Solsona F., et al. Severity of COVID-19 cases in the months of predominance of the alpha and Delta variants. Sci. Rep. 2022;12(1):15456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9472714</ArticleId><ArticleId IdType="pubmed">36104358</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E., Klotz S., Beyerle M., Wischnewski S., Harter V., Kirschner H., et al. Multifactorial white matter damage in the acute phase and pre-existing conditions may drive cognitive dysfunction after SARS-CoV-2 infection: neuropathology-based evidence. Viruses. 2023;15(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10144140</ArticleId><ArticleId IdType="pubmed">37112888</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F., Bruyere A., Doyen M., Bevilacqua S., Charmillon A., Heyer S., et al. Brain (18)F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur. J. Nucl. Med. Mol. Imaging. 2023;50(4):1084&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628394</ArticleId><ArticleId IdType="pubmed">36322190</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., Connolly R., Brennan D., Laffan A., O'Keeffe E., Zaporojan L., et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 2024</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48(9):2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiz R., Gandhi T.K., Mishra S., Prasad A., Mahajan V., Natelson B.H., et al. Assessing functional connectivity differences and work-related fatigue in surviving COVID-negative patients. bioRxiv. 2023</Citation></Reference><Reference><Citation>Henry-Feugeas M-C, Gaudemer A, Lescure X, Dossier A, Sonneville R, Ehmer C, et al. Covid-19 and dysregulated cerebral perfusion: observations with multimodal MRI. medRxiv. 2020:2020.07.12.20100941.</Citation></Reference><Reference><Citation>Hern&#xe1;ndez-Fern&#xe1;ndez F., Sandoval Valencia H., Barbella-Aponte R.A., Collado-Jim&#xe9;nez R., Ayo-Mart&#xed;n &#xd3;., Barrena C., et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089&#x2013;3103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454411</ArticleId><ArticleId IdType="pubmed">32645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho C.Y., Salimian M., Hegert J., O'Brien J., Choi S.G., Ames H., et al. Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol. 2022;79(6):544&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002725</ArticleId><ArticleId IdType="pubmed">35404378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou Z., Yang D., Zhao W., Zeng M., Xie X., et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2022;145(5):1830&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou X., Zhao W., Du Y., Yang D., Huang Y., et al. Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study. Theranostics. 2023;13(2):724&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830428</ArticleId><ArticleId IdType="pubmed">36632218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyams C., Challen R., Marlow R., Nguyen J., Begier E., Southern J., et al. Severity of omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol. United Kingdom. Lancet Reg Health Eur. 2023;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9742675</ArticleId><ArticleId IdType="pubmed">36530491</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A., Renzetti S., van Thriel C., Rechtman E., Patrono A., Ambrosi C., et al. Covid-19 related cognitive, structural and functional brain changes among italian adolescents and young adults: a multimodal longitudinal case-control study. medRxiv. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11447249</ArticleId><ArticleId IdType="pubmed">39358346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., Soret M., Pyatigoskaya N., Habert M.O., Hesters A., Le Guennec L., et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48(8):2543&#x2013;2557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.J., Clijsters M., Backaert W., Vanstapel A., Speleman K., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184(24):5932. 49.e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Clijsters M., Choi S., Backaert W., Claerhout M., Couvreur F., et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron. 2022;110(23):3919. 35.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9647025</ArticleId><ArticleId IdType="pubmed">36446381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W.S.H., Ji X., Roudaia E., Chen J.J., Gilboa A., Sekuler A., et al. MRI assessment of cerebral blood flow in nonhospitalized adults who self-isolated due to COVID-19. J. Magn. Reson. Imaging. 2023;58(2):593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877942</ArticleId><ArticleId IdType="pubmed">36472248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim P.H., Kim M., Suh C.H., Chung S.R., Park J.E., Kim S.C., et al. Neuroimaging findings in patients with COVID-19: a systematic review and meta-analysis. Korean J. Radiol. 2021;22(11):1875&#x2013;1885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546134</ArticleId><ArticleId IdType="pubmed">34269530</ArticleId></ArticleIdList></Reference><Reference><Citation>Klironomos S., Tzortzakakis A., Kits A., &#xd6;hberg C., Kollia E., Ahoromazdae A., et al. Nervous system involvement in coronavirus disease 2019: results from a retrospective consecutive neuroimaging cohort. Radiology. 2020;297(3):E324&#x2013;E334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393954</ArticleId><ArticleId IdType="pubmed">32729812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladopoulos T., Zand R., Shahjouei S., Chang J.J., Motte J., Charles James J., et al. COVID-19: neuroimaging features of a pandemic. J. Neuroimaging. 2021;31(2):228&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014046</ArticleId><ArticleId IdType="pubmed">33421032</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrecq V., Hanin A., Munoz-Musat E., Chougar L., Gassama S., Delorme C., et al. Association of Clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19. JAMA Netw. Open. 2021;4(3):e211489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961310</ArticleId><ArticleId IdType="pubmed">33720371</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan M.T., Smith D.A., Verma G., Khegai O., Saju S., Rashid S., et al. Semi-automated segmentation and quantification of perivascular spaces at 7 tesla in COVID-19. Front. Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9010775</ArticleId><ArticleId IdType="pubmed">35432151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lathouwers E., Radwan A., Blommaert J., Stas L., Tassignon B., Allard S.D., et al. A cross-sectional case-control study on the structural connectome in recovered hospitalized COVID-19 patients. Sci. Rep. 2023;13(1):15668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10514277</ArticleId><ArticleId IdType="pubmed">37735584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., Li W., Maric D., Murray H., et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2021;384(5):481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Steiner J., Pasternack N., Li W., Maric D., et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145(7):2555&#x2013;2568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F., Bund C., Anheim M., Mondino M., Noblet V., Lazzara S., et al. Evolution of neuroimaging findings in severe COVID-19 patients with initial neurological impairment: an observational study. Viruses. 2022;14(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9145920</ArticleId><ArticleId IdType="pubmed">35632691</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Li Y., Zuo L., Hu W., Jiang T. Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment. BMC Neurol. 2021;21(1):159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048027</ArticleId><ArticleId IdType="pubmed">33858381</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Liu J., Lin J., Shang H. COVID-19 and risk of neurodegenerative disorders: a mendelian randomization study. Transl. Psychiatry. 2022;12(1):283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9281279</ArticleId><ArticleId IdType="pubmed">35835752</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu G., Zhang X., Zhang M., Lu J., Li H. Altered intrinsic brain activity and functional connectivity in COVID-19 hospitalized patients at 6-month follow-up. BMC Infect. Dis. 2023;23(1):521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10410836</ArticleId><ArticleId IdType="pubmed">37553613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima M., Siokas V., Aloizou A.M., Liampas I., Mentis A.A., Tsouris Z., et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr. Treat. Options. Neurol. 2020;22(11):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515807</ArticleId><ArticleId IdType="pubmed">32994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z., Li Y., Su P., Mao D., Wei Z., Pillai J.J., et al. Non-contrast MR imaging of blood-brain barrier permeability to water. Magn. Reson. Med. 2018;80(4):1507&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097906</ArticleId><ArticleId IdType="pubmed">29498097</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M., Paes V.R., Cardoso E.F., Neto C., Kanamura C.T., Leite C.D.C., et al. Postmortem brain 7T MRI with minimally invasive pathological correlation in deceased COVID-19 subjects. Insights Imaging. 2022;13(1):7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8760871</ArticleId><ArticleId IdType="pubmed">35032223</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A.L., Carli G., Kiferle L., Piersanti P., Palumbo P., Morbelli S., et al. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur. J. Nucl. Med. Mol. Imaging. 2022;50(1):90&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388976</ArticleId><ArticleId IdType="pubmed">35984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen F.L., Delle C., Nedergaard M. The glymphatic system (en)during inflammation. Int. J. Mol. Sci. 2021;22(14)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305763</ArticleId><ArticleId IdType="pubmed">34299111</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonis G., Filippi C.G., Kirsch C.F.E., Mohan S., Stein E.G., Hirsch J.A., et al. The Spectrum of neuroimaging findings on CT and MRI in adults with COVID-19. AJR Am. J. Roentgenol. 2021;217(4):959&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">33236647</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyaert P., Padrela B.E., Morgan C.A., Petr J., Versijpt J., Barkhof F., et al. Imaging blood-brain barrier dysfunction: a state-of-the-art review from a clinical perspective. Front. Aging Neurosci. 2023;15:1132077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150073</ArticleId><ArticleId IdType="pubmed">37139088</ArticleId></ArticleIdList></Reference><Reference><Citation>Muccioli L., Sighinolfi G., Mitolo M., Ferri L., Jane Rochat M., Pensato U., et al. Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction. Neuroimage Clin. 2023;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10165139</ArticleId><ArticleId IdType="pubmed">37104928</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedergaard M., Goldman S.A. Glymphatic failure as a final common pathway to dementia. Science. 2020;370(6512):50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186542</ArticleId><ArticleId IdType="pubmed">33004510</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcombe V.F.J., Dangayach N.S., Sonneville R. Neurological complications of COVID-19. Intensive Care Med. 2021;47(9):1021&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183330</ArticleId><ArticleId IdType="pubmed">34097083</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesen M., Trotta N., Noel A., Coolen T., Fayad G., Leurkin-Sterk G., et al. Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur. J. Nucl. Med. Mol. Imaging. 2021;48(6):1890&#x2013;1901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781559</ArticleId><ArticleId IdType="pubmed">33398411</ArticleId></ArticleIdList></Reference><Reference><Citation>Normandin E., Valizadeh N., Rudmann E.A., Uddin R., Dobbins S.T., MacInnis B.L., et al. Neuropathological features of SARS-CoV-2 delta and omicron variants. J. Neuropathol. Exp. Neurol. 2023;82(4):283&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10025880</ArticleId><ArticleId IdType="pubmed">36847705</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolini M., Palladini M., Mazza M.G., Colombo F., Vai B., Rovere-Querini P., et al. Brain correlates of subjective cognitive complaints in COVID-19 survivors: a multimodal magnetic resonance imaging study. Eur. Neuropsychopharmacol. 2023;68:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9742225</ArticleId><ArticleId IdType="pubmed">36640728</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons N., Outsikas A., Parish A., Clohesy R., D'Aprano F., Toomey F., et al. Modelling the anatomic distribution of neurologic events in patients with COVID-19: a systematic review of MRI findings. AJNR Am. J. Neuroradiol. 2021;42(7):1190&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324279</ArticleId><ArticleId IdType="pubmed">33888458</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasternak O., Sochen N., Gur Y., Intrator N., Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 2009;62(3):717&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">19623619</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M., N&#xe4;gele F.L., Mayer C., Schell M., Petersen E., K&#xfc;hn S., et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. PNAS. 2023;120(22)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10235949</ArticleId><ArticleId IdType="pubmed">37220275</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;., Garc&#xed;a-Azor&#xed;n D., Guerrero &#xc1;.L., Rodr&#xed;guez M., Aja-Fern&#xe1;ndez S., de Luis-Garc&#xed;a R. Structural brain changes in patients with persistent headache after COVID-19 resolution. J. Neurol. 2023;270(1):13&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9522538</ArticleId><ArticleId IdType="pubmed">36178541</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S., Paolini M., Mazza M.G., Palladini M., Furlan R., Querini P.R., et al. Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors. Eur. Neuropsychopharmacol. 2022;61:71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239982</ArticleId><ArticleId IdType="pubmed">35810586</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Invest. 2021;131(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2021;24(3):368&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes RH, Love GL, Lameira FDS, Sadough MS, Fox SE, Heide RSV. Acute Endotheliitis (Type 3 Hypersensitivity Vasculitis) in Ten COVID-19 Autopsy Brains. medRxiv. 2021:2021.01.16.21249632.</Citation></Reference><Reference><Citation>Ruz-Caracuel I., Pian-Arias H., Corral &#xcd;., Carretero-Barrio I., Bueno-Sacrist&#xe1;n D., P&#xe9;rez-Mies B., et al. Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations. Pathology. 2022;54(6):738&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9182090</ArticleId><ArticleId IdType="pubmed">35691726</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana M.F., Frank C.H.M., Almeida T.V.R., Jeronimo C.M.P., de Ara&#xfa;jo Pinto R.A., Martins Y.F., et al. Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: a large observational study in the brazilian Amazon with a complete autopsy series. PLoS One. 2021;16(9):e0255950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432786</ArticleId><ArticleId IdType="pubmed">34506501</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B., Roos E., Radonic T., Barbe E., Bouman C.S.C., de Boer H.H., et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1(7):e290&#x2013;e299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Sali&#xe9; H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594. 610.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Newman-Norlund R., Riccardi N., Rorden C., Newman-Norlund S., Sayers S., et al. Cerebral blood flow in patients recovered from mild COVID-19. J. Neuroimaging. 2023;33(5):764&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11205277</ArticleId><ArticleId IdType="pubmed">37265421</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano GE, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, et al. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv. 2021:2021.02.15.21251511.</Citation></Reference><Reference><Citation>Shi W., Jiang D., Rando H., Khanduja S., Lin Z., Hazel K., et al. Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study. NeuroImmune Pharm Ther. 2023;2(4):333&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10696574</ArticleId><ArticleId IdType="pubmed">38058998</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LS, Joao RB, Nogueira MH, Aventurato IK, de Campos BM, de Brito MR, et al. Functional and microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19. medRxiv. 2021:2021.03.20.21253414.</Citation></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48(10):3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Keshet A., Graham M.S., Joshi A.D., Shilo S., Rossman H., et al. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Lancet Digit Health. 2021;3(9):e577&#x2013;e586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297994</ArticleId><ArticleId IdType="pubmed">34305035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassignon B., Radwan A., Blommaert J., Stas L., Allard S.D., De Ridder F., et al. Longitudinal changes in global structural brain connectivity and cognitive performance in former hospitalized COVID-19 survivors: an exploratory study. Exp. Brain Res. 2023;241(3):727&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883830</ArticleId><ArticleId IdType="pubmed">36708380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayeri K., Asadollahi K., Madani N., Haghjooy J.S. Does COVID-19 escalate aging process? A Possible Concern. Adv Biomed Res. 2022;11:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843595</ArticleId><ArticleId IdType="pubmed">36660763</ArticleId></ArticleIdList></Reference><Reference><Citation>Teller N., Chad J.A., Wong A., Gunraj H., Ji X., Goubran M., et al. Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: application in COVID-19. Hum. Brain Mapp. 2023;44(10):3998&#x2013;4010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258529</ArticleId><ArticleId IdType="pubmed">37162380</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., Al-Dalahmah O., Banu M.A., Boehme A.K., et al. COVID-19 neuropathology at Columbia University Irving medical Center/New York presbyterian hospital. Brain. 2021;144(9):2696&#x2013;2708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Thunell E., Peter M.G., Lenoir V., Andersson P., Landis B.N., Becker M., et al. Effects of COVID-19 on the human central olfactory system: a natural pre-post experiment. AJNR Am. J. Neuroradiol. 2022;43(12):1777&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pubmed">36423956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T., Wu J., Chen T., Li J., Yan S., Zhou Y., et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI. Insight. 2022;7(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco A.C., Lillie E., Zarin W., O'Brien K.K., Colquhoun H., Levac D., et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 2018;169(7):467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetanov K.A., Spindler L.R.B., Stamatakis E.A., Newcombe V.F.J., Lupson V.C., Chatfield D.A., et al. Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: a prospective observational cohort study. Neuroimage Clin. 2022;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639388</ArticleId><ArticleId IdType="pubmed">36451358</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bussel F.C.G., Backes W.H., Hofman P.A.M., van Oostenbrugge R.J., van Boxtel M.P.J., Verhey F.R.J., et al. Cerebral pathology and cognition in diabetes: the merits of multiparametric neuroimaging. Front. Neurosci. 2017;11:188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380729</ArticleId><ArticleId IdType="pubmed">28424581</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Kerkhof M., van der Thiel M.M., van Oostenbrugge R.J., Postma A.A., Kroon A.A., Backes W.H., et al. Impaired damping of cerebral blood flow velocity pulsatility is associated with the number of perivascular spaces as measured with 7T MRI. J. Cereb. Blood Flow Metab. 2023;43(6):937&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10196747</ArticleId><ArticleId IdType="pubmed">36704826</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Thiel M.M., Backes W.H., Ramakers I., Jansen J.F.A. Novel developments in non-contrast enhanced MRI of the perivascular clearance system: what are the possibilities for alzheimer's disease research? Neurosci. Biobehav. Rev. 2023;144</Citation><ArticleIdList><ArticleId IdType="pubmed">36529311</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Weijden C.W.J., Biondetti E., Gutmann I.W., Dijkstra H., McKerchar R., de Paula F.D., et al. Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status. Brain. 2023;146(4):1243&#x2013;1266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115240</ArticleId><ArticleId IdType="pubmed">36408715</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilev Y., Blokhin I., Khoruzhaya A., Kodenko M., Kolyshenkov V., Nanova O., et al. Routine brain MRI findings on the long-term effects of COVID-19: a scoping review. Diagnostics (basel) 2023;13(15)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10417725</ArticleId><ArticleId IdType="pubmed">37568896</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A., Kas A., Dudouet P., Goehringer F., Salmon-Ceron D., Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: a french multicentric experience. Eur. J. Nucl. Med. Mol. Imaging. 2022;49(9):3197&#x2013;3202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P., Cionca A., Jacot de Alc&#xe2;ntara I., Nuber-Champier A., Allali G., Benzakour L., et al. Brain functional connectivity alterations associated with neuropsychological performance 6&#x2013;9 months following SARS-CoV-2 infection. Hum. Brain Mapp. 2023;44(4):1629&#x2013;1646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878070</ArticleId><ArticleId IdType="pubmed">36458984</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO), 2023, March 28. Coronavirus disease (COVID-19): Post COVID-19 condition. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. Retrieved December 6, 2023, from https://covid19.who.int/?adgroupsurvey=%7Badgroupsurvey%7D&amp;gclid=Cj0KCQiAq5meBhCyARIsAJrtdr73TJulMAcPGlge87Xup_4Rh0tHH8oumayV4yobwVi_7IIN5ECYuTAaApIbEALw_wcB.</Citation></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med. Hypotheses. 2021;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Zhou M., Li L., Luo P., Fan W., Xu J., et al. Characteristics of mental health implications and plasma metabolomics in patients recently recovered from COVID-19. Transl. Psychiatry. 2021;11(1):307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138845</ArticleId><ArticleId IdType="pubmed">34021116</ArticleId></ArticleIdList></Reference><Reference><Citation>Yulug B., Ayy&#x131;ld&#x131;z B., Ayy&#x131;ld&#x131;z S., Sayman D., Salar A.B., Cankaya S., et al. Infection with COVID-19 is no longer a public emergency: but what about degenerative dementia? J. Med. Virol. 2023;95(9):e29072.</Citation><ArticleIdList><ArticleId IdType="pubmed">37724347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yus M., Matias-Guiu J.A., Gil-Mart&#xed;nez L., G&#xf3;mez-Ruiz N., Polidura C., Jorquera M., et al. Persistent olfactory dysfunction after COVID-19 is associated with reduced perfusion in the frontal lobe. Acta Neurol. Scand. 2022;146(2):194&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111206</ArticleId><ArticleId IdType="pubmed">35467007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Gorelik A.J., Wang Q., Norton S.A., Hershey T., Agrawal A., et al. No evidence for the association between COVID-19 and neuroinflammation: a diffusion basis spectrum imaging study. bioRxiv. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10825665</ArticleId><ArticleId IdType="pubmed">38298902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P.P., He Z.C., Yao X.H., Tang R., Ma J., Luo T., et al. COVID-19-associated monocytic encephalitis (CAME): histological and proteomic evidence from autopsy. Signal Transduct. Target. Ther. 2023;8(1):24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9816522</ArticleId><ArticleId IdType="pubmed">36609561</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu J., Hou Y., Leverenz J.B., Kallianpur A., Mehra R., et al. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 2021;13(1):110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189279</ArticleId><ArticleId IdType="pubmed">34108016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>